Clinical Trials

72 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

120 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07470489 2026-04-16

Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer

12 enrolled

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT07533227 2026-04-16

FMT-CACH

66 enrolled

Cachexia, Neoplasms

NCT07172256 2026-04-15

CUE-101with Pembrolizumab for LA-HPV+HNSCCs

30 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07192237 2026-04-15

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

40 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07524894 2026-04-15

SNIFF

126 enrolled

Head and Neck Neoplasms

NCT07530224 2026-04-15

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

Immune Checkpoint Inhibitor-Induced Dermatitis

NCT07530549 2026-04-15

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

40 enrolled

Esophageal Neoplasms

NCT07527169 2026-04-14

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

16 enrolled

Esthesioneuroblastoma, Olfactory

NCT07527325 2026-04-14

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

Dermatologic

Melanoma

NCT07527520 2026-04-14

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

165 enrolled

Rectal Neoplasms

NCT07527806 2026-04-14

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

156 enrolled

Breast Neoplasms

NCT07528417 2026-04-14

MYELO-CAN:ABX

MyeloidOther hematologic neoplasm

75 enrolled

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

NCT07528768 2026-04-14

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

750 enrolled

Triple Negative Breast Neoplasms

NCT07528898 2026-04-14

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

100 enrolled

Breast Neoplasms

NCT07529483 2026-04-14

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts

Pancreatic Cystic Neoplasm

NCT07529873 2026-04-14

N'FORCE

131 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07501169 2026-04-13

STAR-01

33 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07505979 2026-04-13

SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases

90 enrolled

Brain Neoplasms

NCT07521605 2026-04-13

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

44 enrolled

Rectal Cancer Patients

NCT07521657 2026-04-13

NF118

55 enrolled

Glioblastoma, Glioma, Neurofibromatosis 1

NCT07521670 2026-04-13

STRAP

68 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence

NCT07522697 2026-04-13

MITO END-4

48 enrolled

Gynecologic

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms

NCT07522879 2026-04-13

MRG003-SACC

40 enrolled

Carcinoma, Adenoid Cystic

NCT07523607 2026-04-13

FAP PET/CT for Staging Patients With Breast Cancer

65 enrolled

Breast Neoplasms

NCT07524634 2026-04-13

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

64 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT07526597 2026-04-13

STOP-CLL-DCT

LymphoidOther hematologic neoplasm

45 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06084780 2026-04-09

TRANSCAPE

Pseudomyxoma Peritonei

NCT07392970 2026-04-09

Motixafortide for MRD Sensitization in AML

Other hematologic neoplasm

10 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07419464 2026-04-09

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

46 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

NCT07518706 2026-04-09

Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin

Carcinoma, Hepatocellular

NCT07518979 2026-04-09

MH-Penile-002

Genitourinary

Penile Neoplasms

NCT07194980 2026-04-08

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07206849 2026-04-08

Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

79 enrolled

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

NCT07226453 2026-04-08

PNOC041

30 enrolled

Posterior Fossa Ependymal Tumor

NCT07248228 2026-04-08

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

90 enrolled

Brain Neoplasms

NCT07346209 2026-04-08

STRIPe

280 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07354594 2026-04-08

ARREST

120 enrolled

Genitourinary

Prostate Cancer Metastatic Castration-Resistant

NCT07495124 2026-04-08

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

26 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07517640 2026-04-08

Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial

45 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07517653 2026-04-08

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

70 enrolled

Dermatologic

Melanoma

NCT07518160 2026-04-08

JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT07518485 2026-04-08

preReDSeL

Mouth Neoplasms

NCT07513324 2026-04-07

Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

116 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07513389 2026-04-07

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

36 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT07514429 2026-04-07

RELEVANT-HCC

24 enrolled

Carcinoma, Hepatocellular

NCT07514455 2026-04-07

RECOMEND

Carcinoma, Hepatocellular, Disease Progression

NCT07514533 2026-04-07

The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma

Cholangiocarcinoma

NCT07514767 2026-04-07

NOCANO